Literature DB >> 25699155

The role of enhancer of zeste homologue 2 inhibitors in controlling epigenetics and their potential for cancer treatment.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 25699155      PMCID： PMC4329583          DOI： 10.1021/ml5005377

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  EZH2 as a potential target in cancer therapy.

Authors:  Michael T McCabe; Caretha L Creasy
Journal:  Epigenomics       Date:  2014-06       Impact factor: 4.778

Review 2.  EZH2: not EZHY (easy) to deal.

Authors:  Gauri Deb; Anup Kumar Singh; Sanjay Gupta
Journal:  Mol Cancer Res       Date:  2014-02-13       Impact factor: 5.852

Review 3.  EZH2: biology, disease, and structure-based drug discovery.

Authors:  Jin-zhi Tan; Yan Yan; Xiao-xi Wang; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.